Throughout the last three months, 4 analysts have evaluated Omega Therapeutics (NASDAQ:OMGA), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 2 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Omega Therapeutics, revealing an average target of $10.5, a high estimate of $12.00, and a low estimate of $6.00. This current average reflects an increase of 1.65% from the previous average price target of $10.33.
Exploring Analyst Ratings: An In-Depth Overview
A clear picture of Omega Therapeutics's perception...
Login or create a forever free account to read this news
Sign up/Log in
